Quote
Email Us
Citations Search

Targeting FOXK2 in triple-negative breast cancer: Role of the P53/MCAS1/miR-211–5p regulatory axis

Abstract

Total RNA was isolated via RNAiso Plus reagent (TaKaRa, Japan) following the manufacturer’s instructions. Complementary DNA (cDNA) was synthesized via a reverse transcription kit (Takara, Dalian, China). Quantitative real-time PCR was performed to determine the mRNA levels via the SYBR Premix Ex Taq II Kit (TaKaRa, Japan) and primers synthesized by Tsingke (China). The experiments were conducted in triplicate.


Products & Services

Custom DNA Oligo



Article Link >

Contact Us
Explore the power of the Gene Factory and discover how Tsingke's integrated platform accelerates your R&D and product development.
Tsingke Updates
pop_close
pop_main
Subscribe to Our Newsletter

Stay updated with the latest industry news and expert insights. 

Subscribe now to receive:
        ● Industry updates
        ● Exclusive expert insights and analysis
Enter your email to stay ahead!

We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. Part of the tracking is necessary to ensure SEO effectiveness,
By using this site, you agree to our use of cookies. Visit our cookie policy to learn more.
Reject Accept